Two studies in this issue(1,2) indicate that loss-of-function mutations in
the MSX2 homeobox gene result in failure of cranial fontanelle closure in b
oth mouse and human, and that MSX2 dosage is critical to normal osteogenesi
s. Another study, also in this issue, indicates that a loss-of-function mut
ation in MSX1 results in human cleft palate(3). Msx genes interact with oth
er genes (for example, the gene encoding TGF beta 3) to specify normal or c
left palate development, raising the possibilities of both prenatal diagnos
is and therapeutic treatment of human cleft palate. The dose sensitivity an
d interaction of craniofacial genes may be the basis for generating the imp
ortant subtle Variations in human faces.